BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 28095767)

  • 1. In Vivo Quantification of the Deformations of the Femoropopliteal Segment: Percutaneous Transluminal Angioplasty vs Nitinol Stent Placement.
    Gökgöl C; Schumann S; Diehm N; Zheng G; Büchler P
    J Endovasc Ther; 2017 Feb; 24(1):27-34. PubMed ID: 28095767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deformation of the Femoropopliteal Segment: Effect of Stent Length, Location, Flexibility, and Curvature.
    Ní Ghriallais R; Heraty K; Smouse B; Burke M; Gilson P; Bruzzi M
    J Endovasc Ther; 2016 Dec; 23(6):907-918. PubMed ID: 27647689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Stent Implantation on the Deformations of the Superficial Femoral Artery and Popliteal Artery: In Vivo Three-Dimensional Deformational Analysis from Two-Dimensional Radiographs.
    Schumann S; Gökgöl C; Diehm N; Büchler P; Zheng G
    J Vasc Interv Radiol; 2017 Jan; 28(1):142-146. PubMed ID: 28007074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial.
    Iida O; Urasawa K; Komura Y; Soga Y; Inoue N; Hara H; Yajima J; Nakamura S; Ohki T; Ando H; Hirano K; Horita Y; Kichikawa K; Yokoi Y; Miyamoto A; Nakamura M; Takahara M; Mano T; Nanto S
    J Endovasc Ther; 2019 Apr; 26(2):158-167. PubMed ID: 30702021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).
    Kamioka N; Soga Y; Kuramitsu S; Iida O; Hirano K; Suzuki K; Kawasaki D; Yamaoka T; Suematsu N; Shintani Y; Miyashita Y; Takahashi H; Tsuchiya T; Shinozaki N; Okazaki S; Ando K
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):790-797. PubMed ID: 28722294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
    Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O
    J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
    J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitinol self-expanding stents vs. balloon angioplasty for very long femoropopliteal lesions.
    Armstrong EJ; Saeed H; Alvandi B; Singh S; Singh GD; Yeo KK; Anderson D; Westin GG; Dawson DL; Pevec WC; Laird JR
    J Endovasc Ther; 2014 Feb; 21(1):34-43. PubMed ID: 24502482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR;
    J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents.
    Chan YC; Cheng SW; Ting AC; Cheung GC
    J Vasc Surg; 2014 Feb; 59(2):384-91. PubMed ID: 24461862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Rocha-Singh KJ; Beckman JA; Ansel G; Lyden SP; Schneider P; Mehta M; Dake M; Mullin CM; Jaff MR;
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1250-1256. PubMed ID: 28303688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
    Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
    Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Outcomes of Supera Interwoven Nitinol vs Bare Nitinol Stents for the Treatment of Femoropopliteal Disease: Insights From the XLPAD Registry.
    Armstrong EJ; Jeon-Slaughter H; Kahlon RS; Niazi KA; Shammas NW; Banerjee S
    J Endovasc Ther; 2020 Feb; 27(1):60-65. PubMed ID: 31686573
    [No Abstract]   [Full Text] [Related]  

  • 18. Invagination of an Interwoven Nitinol Stent During Femoropopliteal Placement.
    Nakama T; Obunai K; Muraishi M; Kojima S; Watanabe H
    JACC Cardiovasc Interv; 2020 Apr; 13(8):e71-e72. PubMed ID: 32007458
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantification of popliteal artery deformation during leg flexion in subjects with peripheral artery disease: a pilot study.
    Gökgöl C; Diehm N; Kara L; Büchler P
    J Endovasc Ther; 2013 Dec; 20(6):828-35. PubMed ID: 24325701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Morphological Changes of the Femoropopliteal Arteries due to Knee Flexion After Endovascular Treatment of Popliteal Aneurysm.
    Spinella G; Finotello A; Pane B; Salsano G; Mambrini S; Kamenskiy A; Gazzola V; Cittadini G; Auricchio F; Palombo D; Conti M
    J Endovasc Ther; 2019 Aug; 26(4):496-504. PubMed ID: 31198084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.